Update on Transfusion Safety Management Systems Blood Products Advisory Committee Meeting, March 9, 2006 Linda Weir, CSO, CBER/OBRR/DBA.

Slides:



Advertisements
Similar presentations
The Pharmaceutical Agent Order. Prescription An oral or written record of a physicians order to pharmacist to dispense medication to patient.
Advertisements

Regulatory Pathway for Platform Technologies
Radiopharmaceutical Production
Assures that feed… –has the identity and strength, which it purports –meets the quality, purity, and safety requirements, which it is represented to possess.
HIPAA HIPAA Health Insurance Portability and Accountability Act of 1996.
Development of Guidance Documents Jennifer Scharpf, M. P. H
Neoteric Technology Ltd – All Rights Reserved - © 2006
510k Submission Overview Myraqa, Inc. August 22, 2012.
Public Workshop: Quarantine Release Errors in Blood Establishments September 13, 2011 QREs Past, Present and Future Sheryl A. Kochman Deputy Director Division.
Work product of EBG for review and discussion by the FDASIA Regulation Subgroup; May not reflect the subgroup’s views REGULATIONS SUBGROUP PLAN June 14,2013.
CBER 1 Blood Establishment Computer Software (BECS) Michael Gorman, BA, MT(ASCP)SBB Consumer Safety Officer, CBER, OBRR, DBA September 15, 2009.
Enforcement in the Pharmaceutical Industry Michael K. Loucks First Assistant U.S. Attorney United States Attorney’s Office District of Massachusetts October.
CBER Whole Blood and Blood Component Labeling Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Americas Technical Advisory Group ICCBBA ISBT 128 Blood Product Labeling – A Hospital Perspective Americas Technical Advisory Group ICCBBA.
Medical Devices Approval Process
Cross-Labeling: Legal and Regulatory Issues David M. Fox Hogan & Hartson LLP th Street, NW Washington, DC
SMT Proprietary and Confidential
1 Overview of Standards for External Defibrillators: Role of FDA Charles Ho, Ph.D. FDA/CDRH/ODE
CBER Cooperative Manufacturing Arrangements (Contractors) Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 15, 2009.
CDRH Software Regulation
Paul Ashford. Safe Blood? Ensuring the provision of safe blood is a high priority Donor selection Testing Processing Quality assurance But...
CBER Managed Review Process Sheryl A. Kochman Deputy Director, DBA, OBRR, CBER September 15, 2009.
Requirements for Premarket Submissions: In vitro Diagnostic Instrumentation and Software Related to Donor Screening and HIV Diagnostic Assay Systems Diane.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
CBER Blood Establishment Registration and Product Listing Jan O’Brien Blood Registration Coordinator DBA, OBRR, CBER September 15, 2009.
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
FDA Guidance for Industry: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components.
Regulatory Overview.
The Regulatory Authority for Off-Label Promotion
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
CBER 1 Establishment Submissions Rosia E. Nesbitt, BS, SBB(ASCP), CQA(ASQ) Consumer Safety Officer CBER, OBRR, DBA September 15, 2009.
1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.
20__ Fredrikson & Byron P.A A Practical Path -- Does the First Amendment Matter? Presented by Bob Klepinski
Development and Regulation of Medical Products (MEDR-101)
Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
FDA Recommendations: Sampling Plans for Blood Establishments Lore Fields MT(ASCP)SBB Consumer Safety Officer OBRR/CBER/FDA October 19, 2012.
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
FDLI Introduction to Medical Device Law and Regulation Other Postmarket Controls Philip Katz (202) October 29, 2002 Washington,
Revised Recommendations for the Assessment of Donor Suitability: West Nile Virus Sharyn Orton, Ph.D. OBRR/CBER/FDA Blood Products Advisory Committee Meeting.
Dispensary and Administration Site Information Presentation.
REGULATION OF COMBINATION PRODUCTS Mark A. Heller Wilmer Cutler Pickering Hale and Dorr LLP MassMEDIC Combination Product Program, March 28, 2006.
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
Investigational Devices and Humanitarian Use Devices June 2007.
Minimizing the Risks of TSE Agents in Human Tissues Melissa A. Greenwald, M.D. Division of Human Tissues Office of Cellular, Tissue and Gene Therapies;
CBER Common Problems on Source Plasma Inspections Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,
Hemoglobin Device Regulation Josephine Bautista, M.S., MT (ASCP) Senior Advisor for IVD Regulation DRB/DBA/OBRR/CBER Workshop: Hemoglobin standards and.
The 510(k) Program Roy Baby, Investigator US Food & Drug Administration 4040 N Central Expressway, Dallas, TX 1.
Chapter Dental Public Health & Research Contemporary Practice for the Dental Hygienist Copyright ©2011 by Pearson Education, Inc. All rights reserved.
1 Standardize an Organ Coding System for Tracking of Organs: Requirements for OPO TransNet SM Use Operations and Safety Committee Spring 2016.
InstantGMP MD/PRO Electronic Device History File Software for Manufacturing Medical Devices in compliance with 21 CFR Part 820 (Quality System Regulation)
Sample Collection Training Guide. Sample Collection Overview It is the responsibility of the transfusing facility to collect and properly label blood.
The CDRH Software Message (October 19, 2002) John F Murray Jr.. Center for Devices & Radiological Health US Food and Drug Administration
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
CBER Current Considerations for Blood Donor Screening for West Nile Virus Pradip N. Akolkar, Ph.D. Maria Rios, Ph.D. DETTD, OBRR Blood Products Advisory.
Compatibility Testing
UDI Key Features: Medical Device Integration
Premarket Notification 510(k) process
Features and Functionality Presented by: Alan Nichols, MS MT(ASCP)
Combination products The paradigm shift
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
Generic Medical Device Company (“MDC”)
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Regulatory Perspective of the Use of EHRs in RCTs
Radiopharmaceutical Production
Presentation transcript:

Update on Transfusion Safety Management Systems Blood Products Advisory Committee Meeting, March 9, 2006 Linda Weir, CSO, CBER/OBRR/DBA

Purpose ●To provide FDA’s current considerations regarding the regulation of electronic systems for use in matching blood components to the intended recipients

What Are Transfusion Safety Management Systems? ●An electronic system consisting of a barcode scanning device, specialized software, a portable printer (sometimes), and possibly other accessories ●Intended specifically for use in matching blood components to the intended recipient ♦Used to scan the barcode on the blood product and the barcode on the patient arm band at the time of transfusion

What Are Transfusion Safety Management Systems? ●They may be: ♦Stand-alone systems ♦Interfaced to an HIS/LIS ♦Interfaced to a BECS

What Are Transfusion Safety Management Systems? ●They: ♦Are used for positive patient ID at the bedside ♦May be used when the specimen is collected from the patient for compatibility testing ♦Aid in the decision to transfuse or not ♦May be wired or wireless ♦May be used to record vital signs pre and post transfusion ♦May be used to record post-transfusion events

What Are Transfusion Safety Management Systems ♦May be used to track the blood product from the point of issue from the transfusion service, through subsequent refrigeration, to transfusion. ♦May record time out of refrigeration and warn the user if this time is outside of acceptable limits. ♦Track the date and time of transaction and the user ID of the person performing the transaction.

Transfusion Safety Management Systems Are Devices ●Transfusion safety management systems have been determined to be medical devices within the meaning of section 201(h) of the Federal Food, Drug, and Cosmetic Act (Act)[21 U.S.C. 321(h)] ●This is because they are intended to prevent transfusion of blood to the wrong recipient thus preventing incompatible transfusions and associated hemolytic transfusion reactions, i.e. prevention of disease

Transfusion Safety Management Systems Are Also BECS ●Transfusion Safety Management Systems are devices that further meet the definition of Blood Establishment Computer Software (BECS), ♦“…software designed to receive and store data used by blood establishments ▪which includes transfusion services per 21 CFR 607.3(c)) ♦during the manufacturing process ▪(which includes compatibility testing per 21 CFR 607.3(d) ), ♦from determining donor suitability through component processing, testing, and labeling to product release” ▪(From March 31, 1994 letter to manufacturers of blood establishment software:

Transfusion Safety Management Systems Are Also BECS (cont’d) ●Because FDA regulates compatibility testing under 21 CFR , software products used in transfusion services for compatibility testing are also considered to be BECS. ●Transfusion service software products often contain other functionalities consistent with those of BECS, e.g., inventory control, label printing, etc. ●These software products also usually store recipient data such as blood types, known antibodies, etc.

Message to Manufacturers of Transfusion Safety Management Systems ●If you are manufacturing an electronic system intended for use in transfusion management submit a 510(k) if you have not already done so.

21 CFR Meaning of Intended Uses ●“…the objective intent of the persons legally responsible for the labeling of devices. The intent is determined by such persons' expressions or may be shown by the circumstances surrounding the distribution of the article. This objective intent may, for example, be shown by labeling claims, advertising matter, or oral or written statements by such persons or their representatives. ”

Wireless Technology ●Manufacturers of medical devices using wireless technology must consider electromagnetic interference (EMI) and compatibility (EMC) caused by the device. ●We request you provide the requirements as set forth in the recognized consensus standard AAMI/ANSI/ IEC : 2001, Medical Electrical Equipment- Part 1-2: General Requirements for Safety- Collateral Standard: Electromagnetic Compatibility-Requirements and Tests.

Wireless Technology ●The manufacturer of the equipment or system should provide a declaration of conformity to the standard or provide testing results as outlined in AAMI/ANSI/ IEC : 2001 to the FDA in the 510(k) premarket notification

Message to Users of Transfusion Safety Management Systems ●Know if the Transfusion Safety Management System you are considering is intended for use in transfusion management ●If it is, know if the manufacturer has obtained clearance from CBER/FDA ●If it is not, note that your validation burden may be higher

Cleared Systems ●Care Fusion wBloodCare ●Korcheck Technologies CareCheck Patient Identification System ●Neoteric BloodTrack SafeTx ●Neoteric BloodTrack Courier ●

Questions? ●Linda Weir, BECS Expert

Acknowledgements ●Sheryl Kochman, Chief, Devices Review Branch ●Darcel Bigelow, CSO, Devices Review Branch ●Faye Vigue, CSO, Devices Review Branch